DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 76 filers reported holding DYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,822,400 | +61.9% | 315,000 | +103.2% | 1.47% | +11.5% |
| Q2 2023 | $1,743,750 | -2.3% | 155,000 | 0.0% | 1.32% | +33.2% |
| Q1 2023 | $1,785,600 | -9.9% | 155,000 | -7.0% | 0.99% | +81.5% |
| Q4 2021 | $1,981,000 | -26.8% | 166,636 | 0.0% | 0.55% | -23.1% |
| Q3 2021 | $2,706,000 | -22.8% | 166,636 | 0.0% | 0.71% | -12.7% |
| Q2 2021 | $3,506,000 | +35.5% | 166,636 | 0.0% | 0.81% | +13.2% |
| Q1 2021 | $2,588,000 | – | 166,636 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |